Health BARD1 raises $15m for cancer detection tests BARD1 Life Sciences has secured funds from a share placement to develop tests focused on the early detection of ovarian and breast cancer. 23 Jul 2021
Health BARD1 soars on cancer tech update Shares in BARD1 Life Sciences have more than doubled, after the diagnostics business revealed its SubB2M technology can be used to detect all stages of breast cancer. 15 Feb 2021
Deals Biotech companies in $24m merger South Perth-based BARD1 Life Sciences is forming a new cancer diagnostic business with a fellow listed medtech company in Victoria. 09 Apr 2020
